PL2424514T3 - Tapentadol do leczenia bólu w reumatoidalnym zapaleniu stawów - Google Patents
Tapentadol do leczenia bólu w reumatoidalnym zapaleniu stawówInfo
- Publication number
- PL2424514T3 PL2424514T3 PL10721109T PL10721109T PL2424514T3 PL 2424514 T3 PL2424514 T3 PL 2424514T3 PL 10721109 T PL10721109 T PL 10721109T PL 10721109 T PL10721109 T PL 10721109T PL 2424514 T3 PL2424514 T3 PL 2424514T3
- Authority
- PL
- Poland
- Prior art keywords
- tapentadol
- treating rheumatoid
- arthritic pain
- rheumatoid arthritic
- pain
- Prior art date
Links
- 230000002917 arthritic effect Effects 0.000 title 1
- KWTWDQCKEHXFFR-SMDDNHRTSA-N tapentadol Chemical compound CN(C)C[C@H](C)[C@@H](CC)C1=CC=CC(O)=C1 KWTWDQCKEHXFFR-SMDDNHRTSA-N 0.000 title 1
- 229960005126 tapentadol Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09005980 | 2009-04-30 | ||
| EP10721109.6A EP2424514B1 (en) | 2009-04-30 | 2010-04-26 | Tapentadol for treating rheumatoid arthritic pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2424514T3 true PL2424514T3 (pl) | 2017-08-31 |
Family
ID=41050250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10721109T PL2424514T3 (pl) | 2009-04-30 | 2010-04-26 | Tapentadol do leczenia bólu w reumatoidalnym zapaleniu stawów |
Country Status (24)
| Country | Link |
|---|---|
| US (4) | US20100280128A1 (pl) |
| EP (2) | EP2424514B1 (pl) |
| JP (1) | JP5993303B2 (pl) |
| KR (4) | KR20120015332A (pl) |
| CN (2) | CN102438607A (pl) |
| AU (1) | AU2010243907C1 (pl) |
| BR (1) | BRPI1014720A2 (pl) |
| CA (1) | CA2757757C (pl) |
| CY (1) | CY1118822T1 (pl) |
| DK (1) | DK2424514T3 (pl) |
| ES (1) | ES2625949T3 (pl) |
| HR (1) | HRP20170551T1 (pl) |
| HU (1) | HUE032695T2 (pl) |
| IL (1) | IL215695A (pl) |
| LT (1) | LT2424514T (pl) |
| MX (1) | MX2011011442A (pl) |
| MY (1) | MY174008A (pl) |
| PH (1) | PH12017500270A1 (pl) |
| PL (1) | PL2424514T3 (pl) |
| PT (1) | PT2424514T (pl) |
| SG (2) | SG10201401455WA (pl) |
| SI (1) | SI2424514T1 (pl) |
| WO (1) | WO2010124856A1 (pl) |
| ZA (1) | ZA201107708B (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2694049B1 (en) | 2011-04-05 | 2018-10-31 | Grünenthal GmbH | Tapentadol for preventing chronification of pain |
| NO2701693T3 (pl) | 2011-04-29 | 2018-01-20 | ||
| JP6360488B2 (ja) * | 2012-11-01 | 2018-07-18 | トレント・ファーマシューティカルズ・リミテッドＴｏｒｒｅｎｔ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｉｍｉｔｅｄ | 非経口投与のためのタペンタドールの薬学的組成物 |
| CN108227067B (zh) | 2017-11-13 | 2021-02-02 | 南京矽力微电子技术有限公司 | 一种光学结构以及具有该光学结构的电子设备 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4426245A1 (de) | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
| AU2003251993A1 (en) * | 2002-07-19 | 2004-02-09 | Inge Grundke-Iqbal | NMDA RECEPTOR ANTAGONISTS AND THEIR USE IN INHIBITING ABNORMAL HYPERPHOSPHORYLATION OF MICROTUBULE ASSOCIATED PROTEIN tau |
| ATE391498T1 (de) * | 2002-11-22 | 2008-04-15 | Gruenenthal Gmbh | Verwendung von (1rs,3rs,6rs)-6- dimethylaminomethyl-1-(3-methoxy-phenyl)- cyclohexan-1,3-diol zur behandlung von entzündungsschmerz |
| US9125833B2 (en) * | 2005-11-02 | 2015-09-08 | Relmada Therapeutics, Inc. | Multimodal abuse resistant and extended release opioid formulations |
| DE102007019417A1 (de) | 2007-04-23 | 2008-11-13 | Grünenthal GmbH | Tapentadol zur Schmerzbehandlung bei Arthrose |
| CN102065852B (zh) * | 2007-11-23 | 2015-06-17 | 格吕伦塔尔有限公司 | 他喷他多组合物 |
| NZ592437A (en) * | 2008-10-30 | 2013-03-28 | Gruenenthal Chemie | A dosage form comprising tapentadol and an opioid antagonist |
-
2010
- 2010-04-26 MX MX2011011442A patent/MX2011011442A/es active IP Right Grant
- 2010-04-26 SI SI201031443A patent/SI2424514T1/sl unknown
- 2010-04-26 WO PCT/EP2010/002606 patent/WO2010124856A1/en not_active Ceased
- 2010-04-26 ES ES10721109.6T patent/ES2625949T3/es active Active
- 2010-04-26 KR KR1020117028184A patent/KR20120015332A/ko not_active Ceased
- 2010-04-26 KR KR1020197022872A patent/KR20190095522A/ko not_active Ceased
- 2010-04-26 SG SG10201401455WA patent/SG10201401455WA/en unknown
- 2010-04-26 HR HRP20170551TT patent/HRP20170551T1/hr unknown
- 2010-04-26 PL PL10721109T patent/PL2424514T3/pl unknown
- 2010-04-26 AU AU2010243907A patent/AU2010243907C1/en active Active
- 2010-04-26 SG SG2011074283A patent/SG175184A1/en unknown
- 2010-04-26 EP EP10721109.6A patent/EP2424514B1/en not_active Revoked
- 2010-04-26 CN CN201080019155XA patent/CN102438607A/zh active Pending
- 2010-04-26 KR KR1020217006070A patent/KR20210027513A/ko not_active Ceased
- 2010-04-26 CN CN201610050743.9A patent/CN105640927A/zh active Pending
- 2010-04-26 HU HUE10721109A patent/HUE032695T2/en unknown
- 2010-04-26 EP EP16161025.8A patent/EP3069717A1/en not_active Ceased
- 2010-04-26 BR BRPI1014720A patent/BRPI1014720A2/pt not_active IP Right Cessation
- 2010-04-26 JP JP2012507636A patent/JP5993303B2/ja not_active Expired - Fee Related
- 2010-04-26 CA CA2757757A patent/CA2757757C/en active Active
- 2010-04-26 PT PT107211096T patent/PT2424514T/pt unknown
- 2010-04-26 MY MYPI2011004997A patent/MY174008A/en unknown
- 2010-04-26 KR KR1020177000121A patent/KR20170005189A/ko not_active Ceased
- 2010-04-26 LT LTEP10721109.6T patent/LT2424514T/lt unknown
- 2010-04-26 DK DK10721109.6T patent/DK2424514T3/en active
- 2010-04-27 US US12/768,232 patent/US20100280128A1/en not_active Abandoned
-
2011
- 2011-10-11 IL IL215695A patent/IL215695A/en active IP Right Grant
- 2011-10-20 ZA ZA2011/07708A patent/ZA201107708B/en unknown
-
2016
- 2016-08-09 US US15/232,419 patent/US20160346228A1/en not_active Abandoned
-
2017
- 2017-02-13 PH PH12017500270A patent/PH12017500270A1/en unknown
- 2017-04-13 CY CY20171100437T patent/CY1118822T1/el unknown
- 2017-07-31 US US15/664,555 patent/US20170326079A1/en not_active Abandoned
-
2018
- 2018-04-24 US US15/960,909 patent/US20180235909A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE056278T2 (hu) | Elhízás kezelése | |
| GB0920112D0 (en) | Treatment device | |
| IL216013A (en) | Dermatologic Treatment Devices | |
| IL217777A0 (en) | Methods for treatment of pain | |
| EP2409634A4 (en) | ENDOSCOPE OF TREATMENT | |
| IL214919A0 (en) | Method for therapeutic use | |
| EP2482953A4 (en) | BOTTLE FOR A DEVICE FOR TREATING WATER | |
| IL201664A0 (en) | Tapentadol for treating pain from arthritis | |
| IL217492A0 (en) | Treatment method | |
| EP2405929A4 (en) | TREATMENT PROCEDURE FOR AUTOIMMUNE DISEASES | |
| AU331311S (en) | Water treatment device | |
| EP2483207A4 (en) | LIQUID TREATMENT SYSTEM | |
| GB0900599D0 (en) | Treatment | |
| GB201013898D0 (en) | Well treatment | |
| GB0921719D0 (en) | Surgical apparatus | |
| SI2424514T1 (sl) | Tapentadol za zdravljenje revmatoidne artritične bolečine | |
| GB0913968D0 (en) | Treatment | |
| GB0905515D0 (en) | Radiolabelling methods | |
| GB201001521D0 (en) | Treatment | |
| GB0914373D0 (en) | Treatment method | |
| IL198833A (en) | Belt for Healing Disease Freedom Vertebrae is intended | |
| GB0921303D0 (en) | Treatment process | |
| GB0901423D0 (en) | Treatment | |
| GB0915045D0 (en) | Treatment system | |
| GB0916249D0 (en) | Polymer treatment method |